Article Details
Retrieved on: 2022-10-11 23:37:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a major setback, AstraZeneca and the University of Oxford's joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine ...
Article found on: www.news18.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here